Véronique Haddad

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Denis Moro‐Sibilot, Nathalie Cozic, M. Pérol et al. · Annals of Oncology · 2019 · 192 citations · Full text

Medicinal Chemistry, Ros1-positive Nsclc, Medicine +4

Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi

Iwei Yeh, Ursula E. Lang, Emeline Durieux et al. · Nature Communications · 2017 · 131 citations · Full text

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

Nicola Gökbuget, Michael A. Kelsh, Victoria Chia et al. · Blood Cancer Journal · 2016 · 124 citations · Full text

Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi

Sebastian Costa, Michelle L. Byrne, Daniel Pissaloux et al. · The American Journal of Surgical Pathology · 2015 · 113 citations

Blue Nevi, Skin Cancer, Medicine +12

<i><scp>DICER</scp>1</i> and <i><scp>FOXL</scp>2</i> mutations in ovarian sex cord–stromal tumours: a <scp>GINECO</scp> Group study

Thibault Goulvent, Isabelle Ray‐Coquard, Stéphane Borel et al. · Histopathology · 2015 · 109 citations